Why CAR Group, Myer, Neuren, and Yancoal shares are falling today

These shares are having a tough time on hump day. But why?

| More on:
A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is running out of steam and fighting hard to stay in positive territory. In afternoon trade, the benchmark index is up slightly to 8,230.9 points.

Four ASX shares that are weighing on the market today are listed below. Here's why they are falling:

CAR Group Limited (ASX: CAR)

The CAR Group share price is down 1.5% to $37.98. This appears to have been driven by a broker note out of Ord Minnett this morning. According to the note, the broker has downgraded the auto listings company's shares to a hold rating with a $39.00 price target. The broker made the move on valuation grounds after a strong gain on Tuesday drove its shares to a level that is deemed to be fairly valued now.

Myer Holdings Ltd (ASX: MYR)

The Myer share price has continued its slide and is down a further 3% to 81.7 cents. This department store operator's shares are now down almost 30% since this time last week. Investors have been selling Myer's shares following the release of a disappointing trading update. For the 22 weeks ended 28 December, group comparable sales were in line with the prior corresponding period, but total sales were down 0.8% to approximately $1,592 million. And weaker margins led to Myer's EBIT falling approximately 25% to $48 million.

Neuren Pharmaceuticals Ltd (ASX: NEU)

The Neuren Pharmaceuticals share price is down 9% to $10.94. This morning, this pharmaceuticals company announced that its partner Acadia Pharmaceuticals (NASDAQ: ACAD) has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA). This is for trofinetide for the treatment of Rett syndrome in adults and paediatric patients two years of age and older. Acadia anticipates potential approval in the first quarter of 2026. If granted marketing authorisation, trofinetide will be the first and only approved therapy for Rett syndrome in the European Union. The approval timeframe may be longer than some were expecting.

Yancoal Australia Ltd (ASX: YAL)

The Yancoal Australia share price is down 1% to $5.89. This follows news that the coal miner's CEO is stepping down. Yancoal advised that David James Moult will resign after seven years with the company and five years as CEO. Mr Moult decided to retire from full-time employment to devote more time to his other business engagements. His employment will end on 14 July 2025, but active duties have ceased immediately.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the 'five best ASX stocks' for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now...

See The 5 Stocks *Returns as of 9 January 2025

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Car Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Australian Ethical, PYC, Resolute, and Star shares are falling today

These shares are starting the week in the red. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why 4DS, Lynas, REA Group, and Rio Tinto shares are dropping today

These shares are ending the week in the red. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Computershare, Ora Banda, Origin Energy, and Vulcan shares are falling today

These shares are missing out on the good times on Thursday. But why?

Read more »

Shot of a senior scientist looking stressed out while working in a lab.
Healthcare Shares

Why did this $1.4 billion ASX 200 healthcare stock just dive 9%?

The market didn't like what this stock had to say this morning...

Read more »

A male lion with a large mane sits atop a rocky mountain outcrop surveying the view, representing the outlook for the Liontown share price in FY23
Materials Shares

Liontown shares crashed 68% in 2024. Here's why

Investors sent Liontown shares tumbling in 2024.

Read more »

Man with a hand on his head looks at a red stock market chart showing a falling share price.
Share Fallers

Why Mesoblast, Myer, Premier Investments, and Vulcan shares are falling today

These shares are having a tough session on Tuesday. But why?

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why Alkane, Myer, Premier Investments, and St Barbara shares are sinking today

These shares are having a poor start to the week. But why?

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Bank Shares

Why is the Westpac share price being hit so hard today?

The bank is currently the worst-performing member of the big four.

Read more »